Christopher Michael Cashman, President and CEO at MARINUS PHARMACEUTICALS INC (MRNS), bought 28,245 shares at $5.61 ($46K) on 2015-11-06, disclosed to the SEC on 2016-02-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.61 | 3,561 | $20K | 43.8% |
| 2 | $1.04 | 24,684 | $26K | 56.2% |
| Total | $1.62 avg | 28,245 | $46K | 100% |
| Filing → |